• 中国科技核心期刊
  • 中文科技期刊数据库刊源
  • 中国科技论文统计源期刊
  • 美国化学文摘社《化学文摘》刊源
Volume 34 Issue 3
May  2022
Turn off MathJax
Article Contents
Ke ZHOU, Lian-kai WANG, Yu-min WU, Wei LAI, Li ZHANG. Effects of Qishen Yiqi dropping pills on three aspects of patients with CHD after PCI[J]. Chinese Heart Journal, 2022, 34(3): 316-319. doi: 10.12125/j.chj.202106089
Citation: Ke ZHOU, Lian-kai WANG, Yu-min WU, Wei LAI, Li ZHANG. Effects of Qishen Yiqi dropping pills on three aspects of patients with CHD after PCI[J]. Chinese Heart Journal, 2022, 34(3): 316-319. doi: 10.12125/j.chj.202106089

Effects of Qishen Yiqi dropping pills on three aspects of patients with CHD after PCI

doi: 10.12125/j.chj.202106089
  • Received Date: 2021-06-25
  • Rev Recd Date: 2021-09-25
  • Publish Date: 2022-05-26
  •   AIM  To investigate the application of Qishen Yiqi dropping pills in patients with coronary heart disease (CHD) after percutaneous coronary intervention (PCI), and its influence on cardiac functions, physical activity and the incidence of major adverse cardiovascular events (MACE).   METHODS  A total of 84 patients with CHD treated by PCI in Minda Hospital Affiliated to Hubei University for Nationalities were selected between October 2019 and November 2020. Using random number table method, the patients were divided into control group and study group, with 42 patients in each group. The control group was treated with conventional western medicines and the study group was treated with Qishen Yiqi dropping pills based on the treatment of control group. Clinical effects, cardiac functions, TCM syndrome scores, 6-min walking distance, physical activity level and the occurrence of MACE were compared between the two groups.   RESULTS  The total effective rate of clinical treatment in the study group was 92.86%, higher than 76.19% in the control group (P<0.05). After treatment, stroke volume, left ventricular ejection fraction, left ventricular end-systolic diameter, left ventricular end-diastolic diameter, TCM syndrome scores and 6-min walking distance in the study group were better than those in the control group (P<0.01). After treatment, the proportions of patients with high-level and medium-level physical activities in the study group were higher than those in the control group (P<0.05). The incidence of MACE in the study group was 9.52%, significantly lower than 28.57% in the control group (P<0.05).   CONCLUSION  Qishen Yiqi dropping pills increase the stroke volume and ejection fraction, improve cardiac functions, promote physical activity and reduce the incidence of MACE in CHD patients after PCI, which are conducive to the patients’ recovery.

     

  • loading
  • [1]
    刘海伟, 韩雅玲. 冠心病介入抗栓治疗相关最新进展概要[J]. 中华心血管病杂志, 2021, 49(2): 108 – 110. doi: 10.3760/cma.j.cn112148-20201222-01010
    [2]
    Tian Y, Deng P, Li B, et al. Treatment models of cardiac rehabilitation in patients with coronary heart disease and related factors affecting patient compliance[J]. Rev Cardiovasc Med, 2019, 20(1): 27 – 33. doi: 10.31083/j.rcm.2019.01.53
    [3]
    黄传惠, 樊瑞红, 刘洪斌. 中医辨证辅助治疗经皮冠状动脉介入术后心绞痛31例临床观察[J]. 中医杂志, 2019, 60(24): 2118 – 2122. doi: 10.13288/j.11-2166/r.2019.24.012
    [4]
    樊根豪, 邢作英, 陈召起, 等. 芪参益气滴丸治疗冠心病心力衰竭的系统评价[J]. 中国中医基础医学杂志, 2020, 26(7): 932 – 935,997. doi: 10.3969/j.issn.1006-3250.2020.07.022
    [5]
    成 玲, 孟根托娅, 梁俊国. 芪参益气滴丸对PCI术后患者心肌保护作用及不良心血管事件的防治[J]. 中国实验方剂学杂志, 2019, 25(16): 78 – 84. doi: 10.13422/j.cnki.syfjx.20191532
    [6]
    中华医学会. 临床诊疗指南·心血管分册[M]. 北京: 人民卫生出版社, 2009: 65.
    [7]
    中华人民共和国卫生部. 中药新药治疗胸痹(冠心病心绞痛)的临床研究指导原则[S]北京: 中国医药科技出版社, 1993: 41-45.
    [8]
    郑筱萸. 中药新药临床研究指导原则[M]. 北京: 中国医药科技出版社, 2002: 77-85.
    [9]
    ATS committee on proficiency standards for clinical pulmonary function laboratories. ATS statement: guidelines for the six-minute walk test[J]. Am J Respir Crit Care Med, 2002, 166(1): 111 – 117. doi: 10.1164/ajrccm.166.1.at1102
    [10]
    屈宁宁, 李可基. 国际体力活动问卷中文版的信度和效度研究[J]. 中华流行病学杂志, 2004, 25(3): 265 – 268. doi: 10.3760/j.issn:0254-6450.2004.03.021
    [11]
    彭 瑜, 王永祥, 秦红岩, 等. 基于网络药理学的黄芪治疗冠心病机制研究[J]. 中国中西医结合杂志, 2020, 40(8): 935 – 940. doi: 10.7661/j.cjim.20200725.292
    [12]
    张 斌, 马 倩, 马富珍, 等. 黄芪甲苷对心肌细胞缺氧/复氧损伤的保护作用及其自噬机制研究[J]. 四川大学学报(医学版), 2021, 52(2): 222 – 228. doi: 10.12182/20201260601
    [13]
    徐文华, 郑景辉, 赵 阳, 等. 基于网络药理学和生物信息学的丹参酮ⅡA治疗冠心病的分子生物学机制分析[J]. 中草药, 2019, 50(5): 1131 – 1140. doi: 10.7501/j.issn.0253-2670.2019.05.016
    [14]
    王梦梦, 吉兰芳, 崔树娜. 丹参功效的物质基础研究进展[J]. 中医学报, 2019, 34(5): 944 – 949. doi: 10.16368/j.issn.1674-8999.2019.05.225
    [15]
    卢淑立, 冯 妍, 高 杰, 等. 三七提取物在心血管疾病临床应用中的研究进展[J]. 中国全科医学, 2021, 24(5): 539 – 545. doi: 10.12114/j.issn.1007-9572.2020.00.623
    [16]
    谢盈彧, 方子寒, 李渊芳, 等. 基于中药整合药理学平台的芪参益气方对心肌保护的作用机制研究[J]. 中华中医药学刊, 2020, 38(4): 130 – 133. doi: 10.13193/j.issn.1673-7717.2020.04.031
    [17]
    许祖建, 戴小华, 汤丽芬, 等. 芪参益气滴丸对冠心病PCI术后患者心功能及心绞痛疗效的影响[J]. 时珍国医国药, 2019, 30(9): 2208 – 2209. doi: 10.3969/j.issn.1008-0805.2019.09.053
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(6)

    Article views (59) PDF downloads(3) Cited by()
    Proportional views

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return